Actively Recruiting
Post Marketing Study on Pluvicto in Korea
Led by Novartis Pharmaceuticals · Updated on 2025-12-30
278
Participants Needed
8
Research Sites
162 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Post marketing study on Pluvicto in Korea
CONDITIONS
Official Title
Post Marketing Study on Pluvicto in Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male adult patient age 63; 18
- Currently treated with Pluvicto or treatment planned and scheduled by physician according to approved indication in South Korea
- Provided written informed consent before enrollment
You will not qualify if you...
- Medical record is not accessible
- Not willing to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Novartis Investigative Site
Seongnam-si, Gyeonggi-do, South Korea, 13620
Actively Recruiting
2
Novartis Investigative Site
Gyeonggi-do, Korea, South Korea, 10408
Actively Recruiting
3
Novartis Investigative Site
Seoul, Seoul, South Korea, 06351
Actively Recruiting
4
Novartis Investigative Site
Seoul, South Korea, 03722
Actively Recruiting
5
Novartis Investigative Site
Seoul, South Korea, 05505
Actively Recruiting
6
Novartis Investigative Site
Seoul, South Korea, 06591
Actively Recruiting
7
Novartis Investigative Site
Seoul, South Korea, 110-744
Actively Recruiting
8
Novartis Investigative Site
Seoul, South Korea, 139-706
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here